Latest Insider Transactions at Dyne Therapeutics, Inc. (DYN)
This section provides a real-time view of insider transactions for Dyne Therapeutics, Inc. (DYN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Dyne Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Dyne Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
2,640
-1.31%
|
$34,320
$13.41 P/Share
|
|
Sep 05
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
144
-0.15%
|
$1,872
$13.41 P/Share
|
|
Sep 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
873
-0.98%
|
$11,349
$13.41 P/Share
|
|
Sep 04
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
894
-0.93%
|
$11,622
$13.27 P/Share
|
|
Sep 04
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,552
-3.83%
|
$46,176
$13.27 P/Share
|
|
Jul 15
2025
|
John Cox CEO & President |
SELL
Bona fide gift
|
Direct |
40,000
-4.41%
|
-
|
|
Jul 14
2025
|
John Cox CEO & President |
BUY
Open market or private purchase
|
Direct |
100,000
+29.22%
|
$900,000
$9.11 P/Share
|
|
Jun 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,342
-1.43%
|
$17,446
$13.35 P/Share
|
|
Jun 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
4,060
-2.78%
|
$52,780
$13.35 P/Share
|
|
Jun 05
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
146
-0.15%
|
$1,898
$13.35 P/Share
|
|
Mar 31
2025
|
Erick Lucera Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,100
+50.0%
|
-
|
|
Mar 13
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
143
-0.15%
|
$1,716
$12.12 P/Share
|
|
Mar 11
2025
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,153
-1.09%
|
$23,683
$11.38 P/Share
|
|
Mar 11
2025
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,343
-1.09%
|
$14,773
$11.38 P/Share
|
|
Mar 05
2025
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
917
-0.74%
|
$10,087
$11.83 P/Share
|
|
Mar 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
4,061
-2.7%
|
$44,671
$11.83 P/Share
|
|
Mar 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,343
-1.41%
|
$14,773
$11.83 P/Share
|
|
Mar 05
2025
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,094
-0.55%
|
$12,034
$11.83 P/Share
|
|
Feb 18
2025
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,598
-1.29%
|
$33,774
$13.95 P/Share
|
|
Feb 18
2025
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,488
-1.96%
|
$32,344
$13.95 P/Share
|
|
Jan 27
2025
|
Jason P Rhodes |
BUY
Grant, award, or other acquisition
|
Indirect |
1,111,111
+36.2%
|
$14,444,443
$13.5 P/Share
|
|
Dec 11
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,455
-1.13%
|
$40,740
$28.12 P/Share
|
|
Dec 11
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,334
-1.14%
|
$65,352
$28.12 P/Share
|
|
Dec 09
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
34,437
-0.63%
|
$998,673
$29.18 P/Share
|
|
Dec 06
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
101,675
-1.84%
|
$2,948,575
$29.34 P/Share
|
|
Dec 05
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
3,806
-0.07%
|
$110,374
$29.05 P/Share
|
|
Dec 04
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,500
+14.98%
|
-
|
|
Dec 04
2024
|
John Cox CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
145,300
+49.15%
|
-
|
|
Dec 04
2024
|
Douglas Kerr Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,000
+33.45%
|
-
|
|
Dec 04
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+20.28%
|
-
|
|
Dec 04
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
135,039
-2.38%
|
$3,916,131
$29.39 P/Share
|
|
Dec 04
2024
|
Johanna Friedl Naderer Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,800
+28.21%
|
-
|
|
Dec 03
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
29,732
-0.52%
|
$862,228
$29.05 P/Share
|
|
Dec 02
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
81,201
-0.7%
|
$2,436,030
$30.02 P/Share
|
|
Nov 18
2024
|
Carlo Incerti |
SELL
Open market or private sale
|
Direct |
16,500
-100.0%
|
$462,000
$28.73 P/Share
|
|
Nov 18
2024
|
Carlo Incerti |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+50.0%
|
$132,000
$8.69 P/Share
|
|
Nov 18
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,856
-2.03%
|
$79,968
$28.2 P/Share
|
|
Nov 18
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,735
-2.77%
|
$76,580
$28.2 P/Share
|
|
Nov 14
2024
|
Jason P Rhodes |
SELL
Open market or private sale
|
Indirect |
782
-0.01%
|
$25,806
$33.1 P/Share
|
|
Nov 14
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
8,929
-0.15%
|
$285,728
$32.82 P/Share
|
|
Nov 13
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
10,803
-14.78%
|
$378,105
$35.24 P/Share
|
|
Oct 21
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
121
-0.17%
|
$4,235
$35.06 P/Share
|
|
Oct 18
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
13,414
-15.48%
|
$469,490
$35.16 P/Share
|
|
Oct 17
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
13,013
-13.06%
|
$455,455
$35.17 P/Share
|
|
Oct 16
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
23,671
-19.19%
|
$828,485
$35.35 P/Share
|
|
Oct 03
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
5,441
-4.23%
|
$190,435
$35.13 P/Share
|
|
Oct 02
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
21,518
-14.32%
|
$753,130
$35.38 P/Share
|
|
Oct 01
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
8,423
-5.31%
|
$294,805
$35.16 P/Share
|
|
Sep 30
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
30,942
-8.25%
|
$1,082,970
$35.75 P/Share
|
|
Sep 27
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
32
-0.02%
|
$1,120
$35.0 P/Share
|